Amgen price target raised by Truist to $380
Truist Securities maintained Amgen at Hold while raising its price target to $380.00 from $362.00, per Benzinga.
Story updates
03:23:23 PM UTC
SquawkNews
Amgen Is Maintained at Hold by Truist Securities